Outcome | Baseline (M, SD) | 12 weeks (M, SD) | df | t | p | Cohen’s d |
---|---|---|---|---|---|---|
PSS-10 | 18.83 (5.01) | 17.57 (5.54) | 62 | 1.76 | 0.082 | – |
FFA | 2.57 (0.38) | 2.63 (0.34) | 62 | −1.40 | 0.167 | – |
SEQ-12 | 32.73 (32.73) | 37.52 (10.95) | 62 | −3.06 | 0.003** | 0.49 |
L-1 | 5.92 (1.62) | 6.44 (1.86) | 62 | −1.87 | 0.066 | – |
SF12 PH | 16.11 (2.24) | 16.90 (2.08) | 62 | −2.92 | 0.005** | 0.37 |
SF12 MH | 18.87 (3.23) | 19.52 (3.89) | 62 | −1.29 | 0.201 | – |
Baseline (M, SD) | 24 weeks (M, SD) | df | t | p | Cohen’s d | |
---|---|---|---|---|---|---|
PSS-10 | 18.80 (5.17) | 16.69 (5.94) | 53 | 2.63 | 0.011* | 0.38 |
FFA | 2.56 (0.38) | 2.71 (0.37) | 53 | −2.93 | 0.005** | 0.38 |
SEQ-12 | 32.91 (8.80) | 37.87 (13.41) | 53 | −2.90 | 0.026* | 0.44 |
L-1 | 5.87 (1.65) | 6.98 (2.11) | 53 | −3.23 | 0.002** | 0.59 |
SF12 PH | 16.13 (2.11) | 16.89 (2.23) | 53 | −2.67 | 0.010* | 0.35 |
SF12 MH | 18.70 (3.36) | 20.83 (3.77) | 53 | −4.06 | < 0.001*** | 0.60 |